Re: Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial

被引：0
|
作者：
Augugliaro, Matteo [1 ]
Pepa, Matteo [1 ]
Marvaso, Giulia [1 ,2 ]
Jereczek-Fossa, Barbara Alicja [1 ,2 ]
机构：
[1] IEO European Inst Oncol IRCCS, Div Radiat Oncol, Via Ripamonti 435, I-20141 Milan, Italy
[2] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy
来源：
EUROPEAN UROLOGY | 2021年 / 79卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：889 / +
页数：3
相关论文
共 50 条
  • [31] Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
    Siva, Shankar
    Bressel, Mathias
    Murphy, Declan G.
    Shaw, Mark
    Chander, Sarat
    Violet, John
    Tai, Keen Hun
    Udovicich, Cristian
    Lim, Andrew
    Selbie, Lisa
    Hofman, Michael S.
    Kron, Tomas
    Moon, Daniel
    Goad, Jeremy
    Lawrentschuk, Nathan
    Foroudi, Farshad
    EUROPEAN UROLOGY, 2018, 74 (04) : 455 - 462
  • [32] Stereotactic Ablative Radiation Therapy to Lung Metastases Associates with Better Outcomes in Oligometastatic Lung Cancer: Prospective Study
    Blake-Cerda, M.
    Lozano Ruiz, F.
    Maldonado Magos, F.
    De La Mata-Moya, D.
    Diaz-Garcia, D. A.
    Ramirez-Tirado, L.
    Cuevas Gongora, M. F.
    Barron, F.
    Gerson, R.
    Arrieta, O. G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S766 - S767
  • [33] Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Renal Cancer
    Hannan, Raquibul
    McLaughlin, Mark F.
    Pop, Laurentiu M.
    Pedrosa, Ivan
    Kapur, Payal
    Garant, Aurelie
    Ahn, Chul
    Christie, Alana
    Zhu, James
    Wangg, Tao
    Robles, Liliana
    Durakoglugil, Deniz
    Woldu, Solomon
    Margulis, Vitaly
    Gahan, Jeffrey
    Brugarolas, James
    Timmerman, Robert
    Cadeddu, Jeffrey
    EUROPEAN UROLOGY, 2023, 84 (03) : 275 - 286
  • [34] Stereotactic Ablative Radiation Therapy to All Lesions in Patients With Oligometastatic Cancers: A Phase 1 Dose-Escalation Trial
    Mercier, Carole
    Claessens, Michael
    MSc, Andy Buys
    Gryshkevych, Sergii
    Billiet, Charlotte
    Joye, Ines
    Van Laere, Steven
    Vermeulen, Peter
    Meijnders, Paul
    Lofman, Fredrik
    Poortmans, Philip
    Dirix, Luc
    Verellen, Dirk
    Dirix, Piet
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (05): : 1195 - 1205
  • [35] Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial
    Macchia, Gabriella
    Campitelli, Maura
    Pezzulla, Donato
    Lucci, Simona
    Fodor, Andrei
    Russo, Donatella
    Balcet, Vittoria
    Bonome, Paolo
    Durante, Stefano
    Draghini, Lorena
    Titone, Francesca
    D'Agostino, Giuseppe Roberto
    Tamburo, Marinella
    Ferioli, Martina
    Ippolito, Edy
    Tortoreto, Francesca
    Caravatta, Luciana
    De Felice, Francesca
    Di Stefano, Aida
    Fanelli, Mara
    Cilla, Savino
    Cosentino, Francesco
    Marchetti, Claudia
    Salutari, Vanda
    Boccia, Serena
    Morganti, Alessio Giuseppe
    Gambacorta, Maria Antonietta
    Fagotti, Anna
    Pignata, Sandro
    Scambia, Giovanni
    Ferrandina, Gabriella
    Deodato, Francesco
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2025, 121 (03): : 693 - 702
  • [36] Focal radiation for oligometastatic castration-resistant prostate cancer (FORCE): A phase II randomized trial.
    Reichert, Zachery
    Smith, David C.
    Morgan, Todd Matthew
    Piert, Morand
    Tomlins, Scott A.
    Cackowski, Frank Cameron
    Caram, Megan Veresh
    Hearn, Jason W. D.
    Palmbos, Phillip Lee
    Schonewolf, Caitlin
    Yentz, Sarah Elizabeth
    Spratt, Daniel Eidelberg
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis
    F. Deodato
    D. Pezzulla
    S. Cilla
    M. Ferro
    C. Romano
    P. Bonome
    M. Buwenge
    A. Zamagni
    L. Strigari
    V. Valentini
    A. G. Morganti
    G. Macchia
    Clinical and Translational Oncology, 2022, 24 : 1177 - 1183
  • [38] Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis
    Deodato, F.
    Pezzulla, D.
    Cilla, S.
    Ferro, M.
    Romano, C.
    Bonome, P.
    Buwenge, M.
    Zamagni, A.
    Strigari, L.
    Valentini, V.
    Morganti, A. G.
    Macchia, G.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (06): : 1177 - 1183
  • [39] Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial
    Jaccard, Maud
    Zilli, Thomas
    Dubouloz, Angele
    Escude, Lluis
    Jorcano, Sandra
    Linthout, Nadine
    Brat, Samuel
    Verbakel, Wilko
    Bruynzeel, Anna
    Bjorkqvist, Mikko
    Minn, Heikki
    Tsvang, Lev
    Symon, Zvi
    Lencart, Joana
    Oliveira, Angelo
    Ozen, Zeynep
    Abacioglu, Ufuk
    Perez-Moreno, Juan Maria
    Rubio, Carmen
    Rouzaud, Michel
    Miralbell, Raymond
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (04): : 1047 - 1054
  • [40] Phase II trial of stereotactic ablative radiation (SAbR) for oligoprogressive kidney cancer.
    Hannan, Raquibul
    Christensen, Michael
    Garant, Aurelie
    Hammers, Hans J.
    Arafat, Waddah
    Courtney, Kevin Dale
    Bowman, Isaac Alex
    Cole, Suzanne
    Sher, David
    Ahn, Chul
    Timmerman, Robert D.
    Brugarolas, James
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345